Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-230	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The fluorescent nature of DiO allows for visualization of the liposomes in biological systems, facilitating tracking of their distribution and uptake in cells.The DBCO functionalization enables the attachment of various biomolecules, which can help in specific targeting against disease markers or deliver imaging probes.Due to the presence of DOPS, these liposomes can facilitate immune responses and be harnessed in vaccine formulations.	price>
R-Mcs-231	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The far-red fluorescence from DiR allows for non-invasive imaging of liposomes in vivo, useful for tracking distribution and pharmacokinetics.The DBCO moiety allows for the attachment of different biomolecules, creating a versatile platform for developing probes for diagnostics or therapeutic applications.	price>
R-Mcs-232	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based FluoroliposomeDansyl lipid (headgroup)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Dansyl lipid (headgroup)Dansyl lipid (headgroup)-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The DBCO moiety allows for the attachment of different biomolecules, creating a versatile platform for developing probes for diagnostics or therapeutic applications.	price>
R-Mcs-233	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO may also be considered for use as vaccine carriers, enhancing the immune response by facilitating antigen delivery to immune cells.The incorporation of lipids that promote compatibility with biological membranes and the ability to attach therapeutic agents via the DBCO group makes these liposomes valuable for controlled drug delivery.Liposomes labeled with fluorescent or radioactive agents can be used for imaging in biomedical applications, enabling the observation of cellular uptake and distribution.	price>
R-Mcs-234	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome NBD lipid (headgroup)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (headgroup)-DBCO is particularly suitable for targeted drug delivery because of the DBCO moiety which can enable the coupling of therapeutic agents (via azide linkers).The NBD label allows for easy tracking and visualization. This could be essential for studying pharmacokinetics, biodistribution, or cellular uptake in a variety of experimental settings.	price>
R-M1-8762	LNP-cy5/RGD,100nm	Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy).	price>
R-M1-8763	FITC-Ti3C2,200nm-1000nm	FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities.	price>
R-M1-cs8773	CY7@EScu@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments.	price>
R-M1-cs8774	Cyanine7@ES@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ES and CY7 surface modified peptides.By encapsulating ES and CY7 surface-modified peptides within the ROS-responsive liposome nanoparticles, it is possible to achieve targeted delivery or imaging in ROS-rich environments. The surface modifications on the peptides can facilitate specific interactions with the target cells or tissues, while the ROS-responsive nature of the liposomes regulates the release of the peptides in response to the local ROS levels.	price>
R-M1-cs8799	ROS responsive liposomes loaded with CE6	ROS responsive liposomes loaded with CE6 (chlorin e6) are a type of drug delivery system designed to specifically target and respond to reactive oxygen species (ROS) in the body. Upon destabilization, the liposomes release the CE6 into the surrounding tissues. The released CE6 can then undergo a photochemical reaction when activated by specific wavelengths of light, generating highly reactive singlet oxygen species. This localized generation of singlet oxygen can induce cell death, making it particularly suitable for photodynamic therapy (PDT) applications. By specifically targeting and releasing the CE6 in ROS-rich areas, ROS responsive liposomes loaded with CE6 can enhance the therapeutic efficacy of photodynamic therapy while minimizing off-target effects.	price>

...